Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Nonalcoholic Steatohepatitis (Nash) Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Genfit
5.1.1 Genfit Company Profile
5.1.2 Genfit Business Overview
5.1.3 Genfit Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Genfit Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.2 Novo Nordisk
5.2.1 Novo Nordisk Company Profile
5.2.2 Novo Nordisk Business Overview
5.2.3 Novo Nordisk Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Novo Nordisk Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.3 Gilead Science
5.3.1 Gilead Science Company Profile
5.3.2 Gilead Science Business Overview
5.3.3 Gilead Science Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Gilead Science Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.4 Boehringer Ingelheim
5.4.1 Boehringer Ingelheim Company Profile
5.4.2 Boehringer Ingelheim Business Overview
5.4.3 Boehringer Ingelheim Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Boehringer Ingelheim Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.5 Viking Therapeutics
5.5.1 Viking Therapeutics Company Profile
5.5.2 Viking Therapeutics Business Overview
5.5.3 Viking Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Viking Therapeutics Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.6 Connexios Life Sciences
5.6.1 Connexios Life Sciences Company Profile
5.6.2 Connexios Life Sciences Business Overview
5.6.3 Connexios Life Sciences Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Connexios Life Sciences Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.7 Tobira Therapeutics, Inc.
5.7.1 Tobira Therapeutics, Inc. Company Profile
5.7.2 Tobira Therapeutics, Inc. Business Overview
5.7.3 Tobira Therapeutics, Inc. Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Tobira Therapeutics, Inc. Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.8 Galmed Pharmaceuticals Ltd.
5.8.1 Galmed Pharmaceuticals Ltd. Company Profile
5.8.2 Galmed Pharmaceuticals Ltd. Business Overview
5.8.3 Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.9 Nimbus Therapeutics
5.9.1 Nimbus Therapeutics Company Profile
5.9.2 Nimbus Therapeutics Business Overview
5.9.3 Nimbus Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Nimbus Therapeutics Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.10 Verva Pharmaceuticals
5.10.1 Verva Pharmaceuticals Company Profile
5.10.2 Verva Pharmaceuticals Business Overview
5.10.3 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.11 Cerenis Therapeutics
5.11.1 Cerenis Therapeutics Company Profile
5.11.2 Cerenis Therapeutics Business Overview
5.11.3 Cerenis Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Cerenis Therapeutics Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.12 GENFIT SA
5.12.1 GENFIT SA Company Profile
5.12.2 GENFIT SA Business Overview
5.12.3 GENFIT SA Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 GENFIT SA Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.13 Islet Sciences
5.13.1 Islet Sciences Company Profile
5.13.2 Islet Sciences Business Overview
5.13.3 Islet Sciences Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Islet Sciences Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.14 Immuron Ltd
5.14.1 Immuron Ltd Company Profile
5.14.2 Immuron Ltd Business Overview
5.14.3 Immuron Ltd Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Immuron Ltd Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.15 Enzo Biochem, Inc
5.15.1 Enzo Biochem, Inc Company Profile
5.15.2 Enzo Biochem, Inc Business Overview
5.15.3 Enzo Biochem, Inc Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Enzo Biochem, Inc Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.16 Astazeneca Plc
5.16.1 Astazeneca Plc Company Profile
5.16.2 Astazeneca Plc Business Overview
5.16.3 Astazeneca Plc Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Astazeneca Plc Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.17 Intercepts Pharmaceuticals
5.17.1 Intercepts Pharmaceuticals Company Profile
5.17.2 Intercepts Pharmaceuticals Business Overview
5.17.3 Intercepts Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Intercepts Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Nonalcoholic Steatohepatitis (Nash) Sales and Market Share by Types (2015-2020)
6.1.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Market Share by Types (2015-2020)
6.1.3 Global Nonalcoholic Steatohepatitis (Nash) Price by Types (2015-2020)
6.2 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast by Types (2020-2025)
6.2.1 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Weight Loss Treatment
6.3.2 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Insulin-Sensitizing Agents
6.3.3 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Lipid-Lowering Drugs
6.3.4 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Antioxidants
6.3.5 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Other Agents
6.4 Global Nonalcoholic Steatohepatitis (Nash) Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Weight Loss Treatment Market Revenue and Sales Forecast (2020-2025)
6.4.2 Insulin-Sensitizing Agents Market Revenue and Sales Forecast (2020-2025)
6.4.3 Lipid-Lowering Drugs Market Revenue and Sales Forecast (2020-2025)
6.4.4 Antioxidants Market Revenue and Sales Forecast (2020-2025)
6.4.5 Other Agents Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Nonalcoholic Steatohepatitis (Nash) Sales and Market Share by Applications (2015-2020)
7.1.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Market Share by Applications (2015-2020)
7.2 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast by Applications (2020-2025)
7.2.1 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Nonalcoholic Steatohepatitis (Nash) Revenue, Sales and Growth Rate of Phase I (2015-2020)
7.3.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue, Sales and Growth Rate of Phase II (2015-2020)
7.3.3 Global Nonalcoholic Steatohepatitis (Nash) Revenue, Sales and Growth Rate of Phase III (2015-2020)
7.3.4 Global Nonalcoholic Steatohepatitis (Nash) Revenue, Sales and Growth Rate of Clinical Trials (2015-2020)
7.4 Global Nonalcoholic Steatohepatitis (Nash) Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Phase I Market Revenue and Sales Forecast (2020-2025)
7.4.2 Phase II Market Revenue and Sales Forecast (2020-2025)
7.4.3 Phase III Market Revenue and Sales Forecast (2020-2025)
7.4.4 Clinical Trials Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Nonalcoholic Steatohepatitis (Nash) Sales by Regions (2015-2020)
8.2 Global Nonalcoholic Steatohepatitis (Nash) Market Revenue by Regions (2015-2020)
8.3 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast by Regions (2020-2025)

9 North America Nonalcoholic Steatohepatitis (Nash) Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
9.3 North America Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
9.4 North America Nonalcoholic Steatohepatitis (Nash) Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
9.6.1 U.S. Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
9.6.2 Canada Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
9.6.3 Mexico Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate

10 Europe Nonalcoholic Steatohepatitis (Nash) Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
10.3 Europe Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
10.4 Europe Nonalcoholic Steatohepatitis (Nash) Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
10.6.1 Germany Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.2 United Kingdom Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.3 France Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.4 Italy Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.5 Spain Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.6 Russia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate

11 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
11.6.1 China Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11.6.2 Japan Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11.6.3 South Korea Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11.6.4 Australia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11.6.5 India Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate

12 South America Nonalcoholic Steatohepatitis (Nash) Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
12.3 South America Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
12.4 South America Nonalcoholic Steatohepatitis (Nash) Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
12.6.1 Brazil Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
12.6.2 Argentina Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
12.6.3 Columbia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate

13 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
13.6.1 UAE Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
13.6.2 Egypt Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
13.6.3 South Africa Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source